VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
PTGX
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
HomeStocksPTGXInstitutional Holders

PTGX logoProtagonist Therapeutics, Inc. (PTGX) Institutional Ownership

Q2 2026 13F Data|Updated 2026-11-07

✨

Institutional ownership decreased this quarter (-5.00 pp), while top 10 holders maintain a highly concentrated 58.8% of value.

Institutional Ownership
Can exceed 100% due to securities lending, short interest, and reporting timing differences.
118.8%$9.0B total value · ▼ 5.00 pp vs prior quarter
Smart Money Score
Based on ownership concentration, fund quality, buying/selling activity, ownership indicators, and institutional trend.
35 / 100Bearish
Institutions & Flow346 holders+23 net flow (+56 / -33)

AI Insights & Key Takeaways

  • Positive Institutional Flow (+23)
  • Top 10 holders control 58.8% of institutional value
  • No Insider Signal

Top Institutional Holders of PTGX

Ranked by reported Q2 2026 13F market value

Top 10 Holders
58.8%
Top 25 Holders
80.7%

Share of total reported institutional value in PTGX held by the largest 10 / 25 filers.

#InstitutionShares HeldMarket ValueQoQ ChangeOwnership %% of Fund
1BlackRock, Inc.10.3M$1.26B+5.4%16.028%0.02%
2FARALLON CAPITAL MANAGEMENT, L.L.C.6.3M$778.2M0.0%9.872%3.59%
3RTW INVESTMENTS, LP5.1M$620.4M+0.0%7.870%5.30%

Quarterly Institutional Activity

Filings activity in PTGX during Q2 2026, grouped by how each filer changed its position.

OverviewNew Buyers56Added To241Trimmed39Exited33
  • BlackRock, Inc.$1.26B
  • FARALLON CAPITAL MANAGEMENT, L.L.C.$778.2M
  • RTW INVESTMENTS, LP

PTGX Institutional Ownership by Quarter

8 quarters of 13F filings · Δ columns show change vs prior quarter

QuarterInst. HoldersΔ HoldersOwnership %Δ OwnershipTotal 13F ValueΔ Value
Q2 2026346+8.5%118.83%5.00 pp$8.98B+11%
Q1 2026319+0.6%123.83%+8.72 pp$8.09B+33%
Q4 2025317+17%115.11%+1.37 pp$6.06B+33%
Q3 2025271+0.0%113.74%1.47 pp$4.55B+19%
Q2 2025271+2.7%115.21%+8.92 pp$3.83B+26%
Q1 2025264+11%

PTGX — Frequently Asked Questions

Quick answers to the most common questions about buying PTGX stock.

What percentage of PTGX is owned by institutions?

Based on Q2 2026 13F filings, institutional ownership of Protagonist Therapeutics, Inc. stands at 118.8%, held across 346 reporting institutions.

Who is the largest institutional holder of PTGX?

BlackRock, Inc. is the largest reported institutional holder of PTGX, with approximately 10,307,837 shares worth $1.26B as of Q2 2026.

Is PTGX a hedge fund favorite?

No marquee "smart money" managers (Berkshire, Burry, ARK, Tiger Global, Pershing Square, Baupost, etc.) currently appear among the top 25 institutional holders of PTGX.

What is PTGX's Smart Money Score?

Our composite Smart Money Score for PTGX is 35 out of 100 (Bearish). It combines net institutional buying activity, ownership shift, marquee investor presence, and holder-count growth.

How many institutions bought PTGX this quarter?
4VANGUARD PORTFOLIO MANAGEMENT LLC3.6M$444.9M+4.3%5.643%0.02%
5WELLINGTON MANAGEMENT GROUP LLP3.4M$418.8M-5.1%5.313%0.07%
6UBS Group AG3.4M$416.7M-34.4%5.286%0.05%
7STATE STREET CORP3.3M$407.2M+6.6%5.165%0.01%
8VANGUARD CAPITAL MANAGEMENT LLC2.9M$349.8M+1.7%4.437%0.01%
9JOHNSON & JOHNSON2.4M$300.2M0.0%3.808%37.59%
10Invesco Ltd.2.3M$286.9M+8.1%3.640%0.02%
11Jupiter Topco LLC2.1M$261.0M—3.312%0.11%
12GEODE CAPITAL MANAGEMENT, LLC1.7M$213.5M+4.3%2.708%0.01%
13Woodline Partners LP1.4M$173.3M0.0%2.199%0.54%
14BANK OF AMERICA CORP /DE/1.3M$162.4M+2.2%2.059%0.01%
15JENNISON ASSOCIATES LLC1.2M$141.2M+7.4%1.791%0.08%
16PERCEPTIVE ADVISORS LLC982K$120.4M-20.2%1.527%1.81%
17ADAR1 Capital Management, LLC961K$117.8M-3.4%1.494%5.39%
18MORGAN STANLEY906K$111.1M-11.0%1.409%0.01%
19Alyeska Investment Group, L.P.889K$109.0M+49.9%1.383%0.28%
20Hood River Capital Management LLC883K$108.2M+6.5%1.373%0.78%
21GOLDMAN SACHS GROUP INC813K$99.6M+4.3%1.264%0.01%
22DRIEHAUS CAPITAL MANAGEMENT LLC731K$89.6M+1.4%1.137%0.52%
23Clearbridge Investments, LLC725K$88.9M+16.7%1.128%0.07%
24FMR LLC672K$82.4M+1.5%1.045%0.00%
25NORTHERN TRUST CORP666K$81.7M+13.3%1.036%0.01%

denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). “% of Fund” shows how much of that investor’s total 13F portfolio is invested in PTGX — a direct measure of their conviction.

$620.4M
  • VANGUARD PORTFOLIO MANAGEMENT LLC$444.9M
  • WELLINGTON MANAGEMENT GROUP LLP$418.8M
  • STATE STREET CORP$407.2M
  • VANGUARD CAPITAL MANAGEMENT LLC$349.8M
  • JOHNSON & JOHNSON$300.2M
  • Invesco Ltd.$286.9M
  • GEODE CAPITAL MANAGEMENT, LLC$213.5M
  • Woodline Partners LP$173.3M
  • BANK OF AMERICA CORP /DE/$162.4M
  • 106.29%
    +2.12 pp
    $3.03B
    +28%
    Q4 2024238+1.7%104.17%+0.50 pp$2.36B11%
    Q3 2024234—103.67%—$2.67B—

    Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Δ columns compare to the immediately prior filed quarter.

    56 institutions opened new positions in PTGX during Q2 2026, while 33 fully exited. 241 added to existing positions and 39 trimmed.

    How is institutional ownership of PTGX changing?

    PTGX institutional ownership fell by 5.00 percentage points quarter-over-quarter, with a net change of +27 holders.

    How concentrated is PTGX ownership among the top holders?

    The top 10 institutions account for 58.8% of all reported 13F value in PTGX, and the top 25 account for 80.7%.

    Where does this PTGX institutional ownership data come from?

    All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.

    PTGXProtagonist Therapeutics, Inc.
    $132.04$8.5B
    Overview & Tools
    OverviewChart Terminal ↗Visualize
    Valuation & Forecasts
    Valuation ModelsEstimatesDCF Model
    Price & Analyst Data
    Analyst TargetsPrice History
    Financial Statements
    Income StatementBalance SheetCash FlowRatios & Margins
    Performance
    P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
    Discovery & Screens
    Live BreakoutsStock ScreenerOwnership